The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
fenofibric acid · Powder
2 marketed package NDCs · 2 active manufacturers
Most dispensed: 135 mg · Capsule, Delayed Release · #90 capsule, delayed releases/bottle · 45 mg · Capsule, Delayed Release · #90 capsule, delayed releases/bottle · 45 mg · Capsule, Delayed Release · #30 capsule, delayed releases/bottle · 135 mg · Capsule, Delayed Release · #30 capsule, delayed releases/bottle
What changed in the last 90 days
Every detected change for fenofibric acid, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Fenofibric AcidAug 19, 2026Price upNADAC $0.27962 → $0.29469 per unit (+5.39%)
- Fenofibric AcidAug 19, 2026Price downNADAC $0.14993 → $0.14443 per unit (-3.67%)
- Fenofibric AcidAug 19, 2026Price upNADAC $0.27962 → $0.29469 per unit (+5.39%)
- Fenofibric AcidAug 19, 2026Price downNADAC $0.14993 → $0.14443 per unit (-3.67%)
- Fenofibric AcidAug 19, 2026Price upNADAC $0.27962 → $0.29469 per unit (+5.39%)
- Fenofibric AcidAug 19, 2026Price downNADAC $0.14993 → $0.14443 per unit (-3.67%)
- Fenofibric acidAug 19, 2026Price upNADAC $0.27962 → $0.29469 per unit (+5.39%)
- Fenofibric acidAug 19, 2026Price downNADAC $0.14993 → $0.14443 per unit (-3.67%)
- Fenofibric Acid Delayed-ReleaseAug 19, 2026Price upNADAC $0.27962 → $0.29469 per unit (+5.39%)
- Fenofibric Acid Delayed-ReleaseAug 19, 2026Price downNADAC $0.14993 → $0.14443 per unit (-3.67%)
Same drug class
Other molecules FDA puts in Peroxisome Proliferator Receptor alpha Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- alogliptin and pioglitazone· 1 maker
- pioglitazole and metformin hydrochloride· 1 maker
- pioglitazone hcl and metformin hcl· 1 maker
- alogliptin benzoate and pioglitazone hydrochloride· 2 makers
- pioglitazone and glimepiride· 3 makers
- pioglitazone and metformin hydrochloride· 3 makers
- pioglitazone hydrochloride and metformin hydrochloride· 3 makers
- pioglitazone· 19 makers
- pioglitazone hydrochloride· 19 makers
- gemfibrozil· 31 makers
- fenofibrate· 66 makers
Common questions
- Is Fenofibric acid in shortage right now?
- No. FDA does not currently list Fenofibric acid in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Fenofibric acid?
- 11 companies have marketed Fenofibric acid in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Fenofibric acid cost?
- The typical pharmacy pays about $0.2947 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.